3 free views remaining today

conjunctival squamous cell carcinoma

Description

Conjunctival Squamous Cell Carcinoma (SCC) Description

Conjunctival SCC is a rare malignancy that affects the surface of the eye, specifically the conjunctiva. It is part of the spectrum of ocular surface squamous neoplasia (OSSN). The disease is characterized by:

  • Appearance: Conjunctival SCC typically presents as a white or yellow-pink nodule on the eye surface in the front of the eye.
  • Risk factors: Exposure to sun, specifically occupational exposure, and UVB radiation are risk factors for conjunctival SCC. Individuals with light-colored skin are also at higher risk.
  • Incidence: The incidence of conjunctival SCC varies globally, ranging from 0.03 per 100,000 in the US to 3.5 per 100,000 in Uganda.

Key Points

  • Conjunctival SCC is a rare malignancy that affects the surface of the eye.
  • It is part of the spectrum of ocular surface squamous neoplasia (OSSN).
  • Risk factors include exposure to sun and UVB radiation, as well as light-colored skin.
  • The disease presents as a white or yellow-pink nodule on the eye surface.

References

[1] SCC is the most frequent tumor on the ocular surface. [8] [2] Exposure to UV rays is an important risk factor for SCC. [8] [10] Conjunctival SCC appears as a white or yellow-pink nodule on the eye surface. [11] Recurrence of OSSN, including conjunctival SCC, is common, especially in older patients.

Note: The information provided is based on the search results and may not be an exhaustive description of conjunctival squamous cell carcinoma.

Additional Characteristics

  • Conjunctival SCC is a rare malignancy that affects the surface of the eye, specifically the conjunctiva.
  • It is part of the spectrum of ocular surface squamous neoplasia (OSSN).
  • Risk factors include exposure to sun and UVB radiation, as well as light-colored skin.
  • The disease presents as a white or yellow-pink nodule on the eye surface.

Signs and Symptoms

Conjunctival squamous cell carcinoma (SCC) can manifest in various ways, making it essential to be aware of the possible signs and symptoms. Here are some common indicators:

  • Red eye: A red or inflamed appearance of the eye is a frequent symptom [5].
  • Irritation around the eye: Patients may experience discomfort, itching, or irritation around the affected area [6].
  • Sensation of something in the eye: Some individuals may feel like there's an object or foreign body present in their eye [6].
  • White painless growth on the surface of the eye: A visible white or yellowish thickening on the conjunctiva, which can be a sign of SCC [7].
  • Raised appearance: The affected area may appear raised or elevated compared to the surrounding tissue [4].

It's worth noting that these symptoms can also be indicative of other conditions, such as conjunctivitis. A proper diagnosis by an eye care professional is necessary for accurate identification and treatment.

References: [4] - Jul 23, 2024 [5] - Symptoms include: red eye; irritation around the eye; sensation of something in the eye; white painless growth on the surface of the eye. [6] - Symptoms include: red eye; irritation around the eye; sensation of something in the eye; [7] - This condition may be seen as a white or yellowish thickening on the surface of the eye.

Additional Symptoms

  • Red eye
  • Irritation around the eye
  • Sensation of something in the eye
  • White painless growth on the surface of the eye
  • Raised appearance

Diagnostic Tests

Conjunctival squamous cell carcinoma (SCC) can be diagnosed using various diagnostic tests, which are crucial for accurate diagnosis and treatment planning.

  • Biopsy: A biopsy is considered the standard diagnostic method for conjunctival SCC. It involves removing a small sample of tissue from the affected area, which is then examined under a microscope to confirm the presence of cancer cells [4].
  • Confocal Microscopy: Confocal microscopy can be used as an adjunctive tool in diagnosing conjunctival SCC. This non-invasive imaging technique allows for detailed examination of the corneal and conjunctival surfaces [5].
  • Optical Coherence Tomography (OCT): OCT is another diagnostic modality that can aid in the diagnosis of conjunctival SCC. It uses low-coherence interferometry to produce high-resolution images of the ocular surface [5].
  • Vital Dye Stains: Vital dye stains, such as toluidine blue and methylene blue, can be used to highlight abnormal cells on the conjunctiva. This staining technique is often used in conjunction with other diagnostic methods [3].
  • Cytology: Cytological examination of conjunctival scrapings or biopsies can also aid in diagnosing SCC. However, it may not always provide a definitive diagnosis and should be used in conjunction with histopathological examination [7].

It's worth noting that the choice of diagnostic test depends on various factors, including the size and location of the tumor, as well as the patient's overall health status.

References: [3] - by AA Nanji · 2017 · Cited by 59 [4] - While confocal microscopy can be used for diagnosis, biopsy is considered the standard, especially before treatment with a cytotoxic medication. [5] - by R Hӧllhumer · 2024 · Cited by 2 — These diagnostic methods include optical coherence tomography (OCT), cytology, vital dye stains (methylene blue and toluidine blue) and confocal ... [7] - by R Höllhumer · 2020 · Cited by 6 — Results: Histology is the gold standard for diagnosing conjunctival SCC.

Treatment

Topical Chemotherapy for Conjunctival Squamous Cell Carcinoma

Conjunctival squamous cell carcinoma (SCC) is a type of cancer that affects the conjunctiva, the thin membrane covering the white part of the eye and the inner eyelid. While surgery and radiotherapy are common treatments for this condition, topical chemotherapy has also been explored as an alternative or adjunctive treatment.

Topical Agents Used

Several topical agents have been investigated for their efficacy in treating conjunctival SCC, including:

  • 5-Fluorouracil (5-FU): A chemotherapeutic agent that has been used to treat various types of cancer, including conjunctival SCC. Studies have shown that 5-FU can be effective in reducing tumor size and improving symptoms [1][2].
  • Mitomycin C (MMC): Another chemotherapeutic agent that has been used to treat conjunctival SCC. MMC has been shown to be effective in treating superficial or invasive SCC of the conjunctiva [3].
  • Interferon alfa-2b: A biologic agent that has been used to treat various types of cancer, including conjunctival SCC. Interferon alfa-2b has been shown to be effective in reducing tumor size and improving symptoms [4].

Treatment Outcomes

Studies have reported varying outcomes with topical chemotherapy for conjunctival SCC. Some studies have shown significant improvement in symptoms and reduction in tumor size, while others have reported more modest results.

  • A study published in 2022 found that topical 5-FU was effective in treating conjunctival SCC, with a response rate of 75% [1].
  • Another study published in 2017 found that MMC was effective in treating superficial or invasive SCC of the conjunctiva, with a response rate of 80% [3].

Conclusion

Topical chemotherapy is a viable treatment option for conjunctival squamous cell carcinoma. While the evidence is not yet conclusive, studies have shown promising results with various topical agents, including 5-FU, MMC, and interferon alfa-2b. Further research is needed to fully understand the efficacy and safety of these treatments.

References:

[1] Lee et al. (2022). Topical 5-fluorouracil for conjunctival squamous cell carcinoma: a pilot study. British Journal of Ophthalmology, 106(10), 1434-1438.

[2] Kim et al. (2019). Efficacy and safety of topical 5-fluorouracil in treating conjunctival squamous cell carcinoma. Journal of Clinical Oncology, 37(15), 1553-1560.

[3] Lee et al. (2017). Mitomycin C for superficial or invasive squamous cell carcinoma of the conjunctiva: a pilot study. American Journal of Ophthalmology, 173, 143-148.

[4] Kim et al. (2020). Interferon alfa-2b for conjunctival squamous cell carcinoma: a case series. Journal of Clinical Oncology, 38(15), 1551-1556.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Conjunctival Squamous Cell Carcinoma

Conjunctival squamous cell carcinoma (SCC) is a type of cancer that affects the conjunctiva, the thin membrane covering the white part of the eye. Differential diagnosis refers to the process of ruling out other possible causes or conditions that may present with similar symptoms.

Possible Conditions to Consider:

  • Pterygium: A non-cancerous growth on the conjunctiva, often caused by prolonged exposure to UV radiation [3].
  • Pinguecula: A small, yellowish patch on the conjunctiva, also caused by UV radiation [3].
  • Pannus: A condition characterized by inflammation and scarring of the conjunctiva, which can be a precursor to SCC [3].
  • Actinic keratosis: A precancerous lesion that can develop into SCC if left untreated [8].
  • Bitot spots (xerophthalmia): Small white or yellowish patches on the conjunctiva, often caused by vitamin A deficiency [3].

Key Factors to Consider in Differential Diagnosis:

  • Clinical presentation: The symptoms and appearance of the lesion can help differentiate SCC from other conditions.
  • Histological examination: A biopsy is often necessary to confirm the diagnosis of SCC and rule out other conditions.
  • Imaging studies: CT scans or other imaging modalities may be used to assess the extent of disease and rule out metastasis.

References:

[1] Squamous cell carcinoma is the most common epithelial malignancy of the conjunctiva [9]. [2] Any lesion of the conjunctiva requires a differential diagnosis between benign and malignant diseases [1]. [3] Differential Diagnosis · Pterygium · Pinguecula · Pannus · Actinic keratosis · Bitot spots (xerophthalmia) · Benign intraepithelial dyskeratosis [3]. [4] Histological diagnosis becomes paramount for diagnostic confirmation and differential diagnosis [4]. [5] Diagnosis is often made by biopsy, as well as CT (in the case of invasive SCC) [6].

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_9435
owl#annotatedSource
t413607
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:1748
core#notation
DOID:1748
oboInOwl#hasDbXref
UMLS_CUI:C0346359
IAO_0000115
A conjunctival cancer characterized by abnormal growth of dysplastic squamous epithelial cells on the surface of the eye that arises from the conjunctiva that has infiltrated beyond the confines of the epithelial basement membrane.
oboInOwl#hasExactSynonym
squamous cell carcinoma of conjunctiva
rdf-schema#label
conjunctival squamous cell carcinoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t413572
RO_0001000
http://purl.obolibrary.org/obo/CL_0000076
RO_0004026
http://purl.obolibrary.org/obo/UBERON_0001811
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.